The potential for INF™ to treat neuropathy and general nerve pain is incredibly exciting. At Loma Linda University Health, we feel privileged to offer patients new hope for healing with INF™, but know we have only just begun to scratch the surface of what's possible.
Studies are now underway to closely examine how INF™ impacts blood circulation and bone death. This critical understanding will help us further advance INF™ as a treatment model for diabetic and cancer neuropathy patients and consider successful applications to other neurologic and disease applications. We are only just beginning to explore the possibilities before us and the fresh hope this novel treatment could bring to even our most acute patients.
INF™ is a new treatment, however ensuring INF™ is evidenced-based is critical.
The results of a pilot study on this treatment have been published in the Archives of Physical Medicine and Rehabilitation, with two other studies soon to be submitted for publishing. The data coming from the studies is exciting and supports what we are hearing from our patients and seeing in during our treatments.
We've helped people with diabetic neuropathy, chemo-induced neuropathy and idiopathic neuropathy break free from pain. INF™ has shown to be a positive therapeutic with other conditions including with marked improvement noted in sports injuries and various chronic pain conditions.
Perhaps what's most interesting about INF™ research is that we are able to explore new, powerful avenues for healing using the body's neural microvascular system. The success of INF™ demonstrates it's possible to actually manipulate circulation back to the nerve.
Our researchers and scientists are diving deeper into the exploration of this novel therapeutic intervention to unlock its potential and apply its natural restorative effects to an even broader array of diseases.